AIM
CSBR icon

Alambic Investment Management’s Champions Oncology CSBR Stock Holding History

Alambic Investment Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,676
Closed -$86K – 173
2020
Q1 		$86K Sell
11,676
-2,094
-15% -$14.6K 0.21% 139
2019
Q4 		$115K Sell
13,770
-29,557
-68% -$182K 0.1% 239
2019
Q3 		$245K Sell
43,327
-25,354
-37% -$164K 0.18% 190
2019
Q2 		$538K Buy
68,681
+14,614
+27% +$128K 0.33% 127
2019
Q1 		$529K Buy
54,067
+26,557
+97% +$265K 0.22% 163
2018
Q4 		$215K Buy
+27,510
New +$316K 0.09% 249

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

Alambic Investment Management's CSBR Position: Q2 2020 in Review

Alambic Investment Management sold out of Champions Oncology (CSBR) in Q2 2020, closing a stake of 11,676 shares — an estimated $86K sold.

Alambic Investment Management first reported a position in CSBR in Q4 2018 and held it in 6 quarters. The position peaked at $538K in Q2 2019. 44 funds tracked by Wall St. Rank hold CSBR as of Q2 2020.

  • Alambic Investment Management reported no remaining Champions Oncology position as of Q2 2020 after selling out during the quarter.
  • Alambic Investment Management sold 11,676 Champions Oncology shares in Q2 2020, an estimated $86K.
  • Alambic Investment Management first reported a position in Champions Oncology in Q4 2018 and held it in 6 quarters.
  • Alambic Investment Management's Champions Oncology position peaked at $538K in Q2 2019.
  • 44 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2020.

Based on Alambic Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.